The research group’s comprehensive five-year roadmap begins in Year 1 with Cluster Settlement and Initial Research, focusing on foundational activities such as market research, cluster socialization, and focus group discussions (FGDs) with stakeholders. During this initial phase, the team will also inventory potential materials, develop advanced delivery systems, and prepare CPKB and CPOTB facilities. Moving into Year 2, the focus shifts to Product Development, which involves standardizing raw materials, establishing Safety Data Sheets, and assuring raw material quality. This year also encompasses the development of finished cosmetic and supplement products, patent drafting, and initiating contract manufacturing for both raw materials and finished goods. In Year 3, the group transitions to Scaling Up, prioritizing product scale-up, security and quality assessments, clinical testing, and navigating official notification and registration processes. Year 4 is dedicated to Product Commercialization, highlighted by the marketing of active ingredients, excipients, and finished products, alongside the publication of policy briefs. Finally, Year 5 centers on Surveillance, focusing on securing patent licensing with industry partners and maintaining ongoing product surveillance in the market.